Remels, A H V <br/><br/>
PPARgamma inhibits NF-kappaB-dependent transcriptional activation in skeletal muscle.  [electronic resource] 

 -  American journal of physiology. Endocrinology and metabolism  Jul 2009 
 - E174-83 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1522-1555 
<br/><br/><label>Standard No.: </label>10.1152/ajpendo.90632.2008  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Cells, Cultured<br/>Cytokines--pharmacology<br/>Down-Regulation--drug effects<br/>Humans<br/>Hypoglycemic Agents--pharmacology<br/>Inflammation Mediators--pharmacology<br/>Male<br/>Mice<br/>Middle Aged<br/>Muscle, Skeletal--drug effects<br/>NF-kappa B--antagonists & inhibitors<br/>PPAR gamma--agonists<br/>Pyrimidines--pharmacology<br/>Rosiglitazone<br/>Thiazoles--pharmacology<br/>Thiazolidinediones--pharmacology<br/>Transcriptional Activation--drug effects